Clinicopathological factor | n | LncRNA RGMB-AS1 expression(2–ΔCt) | RGMB mRNA expression(2–ΔCt) | ||
---|---|---|---|---|---|
 |  | Median ± SD | P | Media ± SD | P |
Gender | Â | Â | Â | Â | Â |
Male | 47 | 0.0734 ± 0.0641 | 0.847 | 0.4148 ± 0.2016 | 0.301 |
Female | 25 | 0.0763 ± 0.0557 |  | 0.3656 ± 0.1684 |  |
Age(years) | Â | Â | Â | Â | Â |
≥60 | 28 | 0.0634 ± 0.0638 | 0.226 | 0.4320 ± 0.2111 | 0.227 |
<60 | 44 | 0.0814 ± 0.0587 |  | 0.3759 ± 0.1761 |  |
Histology | Â | Â | Â | Â | Â |
SCC | 44 | 0.0718 ± 0.0584 | 0.662 | 0.4020 ± 0.1989 | 0.812 |
Adeno | 28 | 00784 ± 0.0656 |  | 0.3909 ± 0.1813 |  |
Differentiation | Â | Â | Â | Â | Â |
Well | 16 | 0.0269 ± 0.0323 | 0.007* | 0.5292 ± 0.1771 | 0.032* |
Moderate | 39 | 0.0556 ± 0.0378 |  | 0.4299 ± 0.1633 |  |
Poor | 17 | 0.1622 ± 0.0281 |  | 0.2000 ± 0.0883 |  |
Lymphnode metastasis | Â | Â | Â | Â | Â |
Positive | 37 | 0.1146 ± 0.0514 | 0.000* | 0.3169 ± 0.1640 | 0.000* |
Negative | 35 | 0.0319 ± 0.0367 |  | 0.4832 ± 0.1819 |  |
TNM | Â | Â | Â | Â | Â |
I + II | 31 | 0.0265 ± 0.0326 | 0.000* | 0.5068 ± 0.1751 | 0.007* |
III + IV | 41 | 0.1106 ± 0.0517 |  | 0.3152 ± 0.1598 |  |